Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: urslor who wrote (56151)	5/4/2020 10:37:29 AM
From: KeeptheFaith	4 Recommendations Recommended By idahoranch1 jargonweary jhcimmu summer_sky Respond to of 63324

I am unsure of accounting rules for revenue recognition for the sale of Trodelvy. I doubt it is cash basis, but rather accrued after estimating rebates. The question is when is the revenue accrued? At point of sale, day of shipment, day of billing regardless of when product is used in patient, etc.? At any rate, I do not think IMMU is waiting for a check to clear from an insurance company prior to recording revenue. - KTF pwc.fr